Pfizer lays off hundreds of US sales rep as fewer in-person meetings expected to remain permanent
Pfizer is cutting its US sales staff to adjust to the permanent shift to digital promotions and away from in-person meetings. It plans to eliminate a few hundred sales force positions, but at the same time, will add back about half that same number of jobs in newly created positions that will engage with HCPs in the ways they want going forward.
In a statement, a spokesman said Pfizer is “evolving into a more focused and innovative biopharma company, and evolving the way we engage with healthcare professionals in an increasingly digital world. There will be some changes to our workforce to ensure we have the right expertise and resources in place to meet our evolving needs. We value the significant contributions of our employees, and any impacted colleagues will be appropriately supported through this transition.”
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 159,000+ biopharma pros reading Endpoints daily — and it's free.